Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2-positive breast cancer cells in vitro and in vivo

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1921-1926

  Liu, Weihua ^a   Xu, Jinmei ^a   Liu, Yilun ^a   Yu, Xiaoping ^a   Tang, Xi ^a   Wang, Zhi ^a   Li, Xin ^a  

^a CHENGDU MEDICAL COLLEGE   (China)

Author keywords

Anthocyanins; Cyanidin 3 glucoside; Drug combination; Synergism

Indexed keywords

ANTHOCYANIN; ANTINEOPLASTIC AGENT; CYANIDIN 3-O-GLUCOSIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; GLUCOSIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; PEONIDIN 3-GLUCOSIDE; PROTEIN KINASE B; TRASTUZUMAB;

ANIMAL; APOPTOSIS; BREAST NEOPLASMS; DRUG EFFECTS; DRUG POTENTIATION; FEMALE; HUMAN; KIDNEY; LIVER; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; SPLEEN; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTHOCYANINS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SYNERGISM; FEMALE; GLUCOSIDES; HUMANS; KIDNEY; LIVER; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; SPLEEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 84924220252     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2414     Document Type: Article

References (20)

1. American Cancer Society: Cancer Facts & Figures 2013. American Cancer Society, Atlanta, 2013.
2. Lv F, Yu Y, Zhang B, Liang D, Li ZM and You W: Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms. J Huazhong Univ Sci Technolog Med Sci 33: 870-876, 2013.
3. Vrbic S, Pejcic I, Filipovic S, Kocic B and Vrbic M: Current and future anti-HER2 therapy in breast cancer. J BUON 18: 4-16, 2013.
4. Marty M, Cognetti F, Maraninchi D, et al: Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23: 4265-4274, 2005. (Pubitemid 46207001)
5. Neve RM, Chin K, Fridlyand J, et al: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527, 2006. (Pubitemid 44854747)
6. Slamon DJ, Leyland-Jones B, Shak S, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Eng J Med 344: 783-792, 2001. (Pubitemid 32222155)
7. Huang C, Lee SY, Lin CL, et al: Co-treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-β-d-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 cells. J Agric Food Chem 61: 6430-6445, 2013.
8. Wu XQ, Shao SJ and Qu WC: Effects of ru'ai shuhou recipe on the matrix metalloproteinases and the inhibitive factors in the recurrence and metastasis of HER2 positive breast cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jie He Za Zhi 32: 1526-1530, 2012 (In Chinese).
9. Liu W, Xu J, Wu S, et al: Selective anti-proliferation of HER2-positive breast cancer cells by anthocyanins identified by high-throughput screening. PloS One 8: e81586, 2013.
10. Chen XQ, Nagao N, Itani T and Irifune K: Anti-oxidative analysis and identification and quantification of anthocyanin pigments in different coloured rice. Food chem 135: 2783-2788, 2012.
11. Fernandes I, Faria A, Azevedo J, et al: Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation. J Agric Food Chem 58: 3785-3792, 2010.
12. Bunea A, Rugina D, Sconta Z, et al: Anthocyanin determination in blueberry extracts from various cultivars and their antiproliferative and apoptotic properties in B16-F10 metastatic murine melanoma cells. Phytochemistry 95: 436-444, 2013.
13. Fernandes I, Marques F, de Freitas V and Mateus N: Antioxidant and antiproliferative properties of methylated metabolites of anthocyanins. Food Chem 141: 2923-2933, 2013.
14. Heinonen M: Antioxidant activity and antimicrobial effect of berry phenolics - a Finnish perspective. Mol Nutr Food Res 51: 684-691, 2007.
15. Iriti M and Varoni EM: Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies. Nutrients 5: 2564-2576, 2013.
16. Kamenickova A, Anzenbacherova E, Pavek P, et al: Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell lines. Toxicol Lett 21: 1-8, 2013.
17. Chen PN, Chu SC, Chiou HL, Kuo WH, Chiang CL and Hsieh YS: Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett 235: 248-259, 2006.
18. Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF and Hsieh YS: Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53: 232-243, 2005.
19. Ding M, Feng R, Wang SY, et al: Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem 281: 17359-17368, 2006.
20. Cooke D, Schwarz M, Boocock D, et al: Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis - relationship with tissue anthocyanin levels. Int J cancer 119: 2213-2220, 2006. (Pubitemid 44423683)